Elevated levels of SERPINE1 are significantly correlated with unfavorable clinical features and a poor prognosis in GC patients (Liao et al., 2018; Liu et al., 2018), suggesting a pro-tumor effect of SERPINE1 in gastric tumorigenesis. This evidence concerns the gene SERPINE1 and neoplasm.